Literature DB >> 9550407

Comparison of the roles of CD8 alpha alpha and CD8 alpha beta in interaction with MHC class I.

J Sun1, P B Kavathas.   

Abstract

The CD8 molecule is expressed either as an alpha/alpha homodimer or an alpha/beta heterodimer on thymocytes and cytotoxic T cells, and functions as a coreceptor in concert with TCR for binding the MHC class I/peptide complex. Although CD8alpha/beta heterodimers have been shown to be more effective coreceptors, the precise role of the beta-chain in TCR-mediated thymic maturation and T cell activation is not understood. To understand the role of CD8beta in mediating CD8/MHC class I interaction, we examined whether cell surface CD8alpha/beta heterodimer promotes better cell-cell adhesion with MHC class I than the CD8alpha/alpha homodimer. The abilities of different forms of CD8 to adhere to MHC class I were measured with a cell-cell binding assay. Using a wild-type CD8beta and -alpha, we found that CD8alphabeta heterodimers did not mediate greater cell-cell adhesion than CD8alphaalpha homodimers. Furthermore, we found that chimeric CD8beta-alpha homodimers afforded no detectable binding. These results do not support the idea that CD8alphabeta binding to MHC class I is greater than that of CD8alphaalpha. Rather, they point to an alternative explanation in which CD8beta may play an role in promoting CD8/TCR interaction and/or in signaling/regulatory pathways.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9550407

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Significance of unconventional peripheral CD4+CD8dim T cell subsets.

Authors:  Claude Lambert; Lambert Claude; Mohammad Ibrahim; Ibrahim Mohammad; Cristina Iobagiu; Iobagiu Cristina; Christian Genin; Genin Christian
Journal:  J Clin Immunol       Date:  2005-09       Impact factor: 8.317

Review 2.  Molecular analysis of protein interactions mediating the function of the cell surface protein CD8.

Authors:  L Devine; P B Kavathas
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

3.  Transcription variants of SLA-7, a swine non classical MHC class I gene.

Authors:  Rui Hu; Gaëtan Lemonnier; Emmanuelle Bourneuf; Silvia Vincent-Naulleau; Claire Rogel-Gaillard
Journal:  BMC Proc       Date:  2011-06-03

4.  An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammals.

Authors:  F Tilloy; E Treiner; S H Park; C Garcia; F Lemonnier; H de la Salle; A Bendelac; M Bonneville; O Lantz
Journal:  J Exp Med       Date:  1999-06-21       Impact factor: 14.307

5.  Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region.

Authors:  Linda Wooldridge; Anna Lissina; Jonathan Vernazza; Emma Gostick; Bruno Laugel; Sarah L Hutchinson; Fareed Mirza; P Rod Dunbar; Jonathan M Boulter; Meir Glick; Vincenzo Cerundolo; Hugo A van den Berg; David A Price; Andrew K Sewell
Journal:  Eur J Immunol       Date:  2007-05       Impact factor: 5.532

6.  Establishment of a novel platform cell line for efficient and precise evaluation of T cell receptor functional avidity.

Authors:  Soyoko Morimoto; Fumihiro Fujiki; Kenta Kondo; Hiroko Nakajima; Yoshiki Kobayashi; Miki Inatome; Nao Aoyama; Yuya Nishida; Akihiro Tsuboi; Yoshihiro Oka; Sumiyuki Nishida; Jun Nakata; Naoki Hosen; Yusuke Oji; Haruo Sugiyama
Journal:  Oncotarget       Date:  2018-09-25

7.  Human Peripheral Blood Gamma Delta T Cells: Report on a Series of Healthy Caucasian Portuguese Adults and Comprehensive Review of the Literature.

Authors:  Sónia Fonseca; Vanessa Pereira; Catarina Lau; Maria Dos Anjos Teixeira; Marika Bini-Antunes; Margarida Lima
Journal:  Cells       Date:  2020-03-16       Impact factor: 6.600

8.  Inverted CD4+/CD8+ T cell ratio in Boran (Bos indicus) cattle.

Authors:  Maurine C Makau; Jessica Powell; James Prendergast; Perle Latré de Laté; Liam J Morrison; Andressa Fisch; Peter Gathura; Phillip Kitala; Timothy Connelley; Philip Toye
Journal:  Vet Immunol Immunopathol       Date:  2020-10-06       Impact factor: 2.046

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.